Boundless Bio Ownership | Who Owns Boundless Bio?

Boundless Bio Ownership Summary

Boundless Bio is owned by 193.46% institutional investors.

BOLD Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Boundless Bio	193.46%	-	-93.46%
Sector	Healthcare Stocks	47.25%	8.01%	44.75%
Industry	Biotech Stocks	45.35%	7.81%	46.83%

Recent Insider Transactions

Date	Name	Role	Activity	Value
Nov 08, 2019	Patterson Matthew R	Chief Executive Officer	Sell	$432.78K
Aug 12, 2019	Patterson Matthew R	Chief Executive Officer	Sell	$34.52K
Aug 12, 2019	Patterson Matthew R	Chief Executive Officer	Sell	$646.31K
Feb 25, 2019	Patterson Matthew R	Chief Executive Officer	Sell	$120.00K
Oct 01, 2018	Patterson Matthew R	Chief Executive Officer	Sell	$202.73K

BOLD Ownership FAQ

Who Owns Boundless Bio?

Boundless Bio shareholders are primarily institutional investors at 193.46%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Boundless Bio's industry, Biotech Stocks , is 45.35%, which Boundless Bio exceeds.

Does Blackrock own Boundless Bio?

BlackRock is not among the top 10 institutional shareholders of Boundless Bio.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools